A Pilot Study of CBG/CBD Oil for Chemotherapy-Induced Neuropathy

Recruiting Phase 1 NCT07016971

Study Description

Evaluating a Cannabinoid Oil for Relieving Neuropathy from Chemotherapy

Study Details

Registry ID:
NCT07016971
Conditions:
Chemotherapy-Induced Peripheral Neuropathy
Phase:
Phase 1
Target Enrollment:
12 participants
Start Date:
Age Range:
21–999 years
Healthy Volunteers:
No

Study Locations (1 site)

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →